(Q53500222)

English

Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report.

scientific article published in January 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

0 references

1 reference

based on heuristic

inferred from title

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A Cull

1

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

S Howat

2

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

E Greimel

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

A C Waldenstrom

4

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

J Arraras

5

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

A Kudelka

6

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

L Chauvenet

7

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

A Gould

8

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

EORTC Quality of Life Group [European Organization for Research and Treatment of Cancer]

9

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

Scottish Gynaecological Cancer Trials Group

10

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

37

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

1

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

47-53

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900369-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900369-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for ovarian cancer--a consensus statement on standard practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900369-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced epithelial ovarian cancer: 1998 consensus statements

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900369-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Palliative therapy in advanced ovarian cancer: balancing patient expectations, quality of life and cost

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900369-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of recurrent ovarian carcinoma: balancing patient desires, therapeutic benefit, cost containment and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900369-5

7 January 2021

based on heuristic

inferred from DOI database lookup

What has been learned from measuring health-related quality of life in clinical oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900369-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900369-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Perceptions of cisplatin-related toxicity among ovarian cancer patients and gynecologic oncologists

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900369-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900369-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900369-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900369-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900369-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life in patients with ovarian cancer: current state of research

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900369-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900369-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Coefficient alpha and the internal structure of tests

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900369-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(00)00369-5

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/11165129

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53500222&oldid=1412721596"